28-Mar-2024
No headlines found.
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results
PRNewswire (Fri, 22-Mar 7:00 AM ET)
Business Wire (Wed, 14-Feb 7:00 AM ET)
VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.
Vbi Vaccines - trades on the NASDAQ stock market under the symbol VBIV.
As of March 28, 2024, VBIV stock price climbed to $0.60 with 117,983 million shares trading.
VBIV has a beta of 3.40, meaning it tends to be more sensitive to market movements. VBIV has a correlation of 0.08 to the broad based SPY ETF.
VBIV has a market cap of $14.27 million. This is considered a Sub-Micro Cap stock.
Last quarter Vbi Vaccines - reported $7 million in Revenue and -$.38 earnings per share. This fell short of revenue expectation by $-7 million and missed earnings estimates by -$.24.
In the last 3 years, VBIV stock traded as high as $129.30 and as low as $.45.
The top ETF exchange traded funds that VBIV belongs to (by Net Assets): VXF, URTY.
VBIV has underperformed the market in the last year with a return of -93.3%, while the SPY ETF gained +33.6%. In the last 3 month period, VBIV fell short of the market, returning +5.3%, while SPY returned +10.1%. However, in the most recent 2 weeks VBIV has outperformed the stock market by returning +2.1%, while SPY returned +1.7%.
VBIV support price is $.56 and resistance is $.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VBIV stock will trade within this expected range on the day.